XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Total revenue, net $ 89,878 $ 142,038 $ 278,948 $ 438,696
Less: Cost of goods sold 23,941 30,211 81,990 90,692
Less: Cost of goods sold - restructuring inventory 3,078   18,078  
Gross margin 62,859 111,827 178,880 348,004
Operating expenses:        
Selling, general and administrative 58,745 102,965 236,285 315,966
Research and development 5,765 7,820 25,172 23,554
Restructuring 3,493 14,115 13,706 14,115
Total operating expenses 68,003 124,900 275,163 353,635
Operating loss (5,144) (13,073) (96,283) (5,631)
Interest income, net 750 163 1,241 919
Other income (expense), net 511 (57) (1,990) (390)
Loss from operations before taxes (3,883) (12,967) (97,032) (5,102)
Income tax provision (1,257) (184) (9,627) (1,867)
Net loss $ (5,140) $ (13,151) $ (106,659) $ (6,969)
Loss per share:        
Basic $ (0.01) $ (0.03) $ (0.27) $ (0.02)
Diluted $ (0.01) $ (0.03) $ (0.27) $ (0.02)
Weighted average shares:        
Basic 404,614 396,618 399,944 395,681
Diluted 404,614 396,618 399,944 395,681
Product Revenue, Net        
Total revenue, net $ 89,222 $ 141,442 $ 277,004 $ 436,598
Licensing and Royalty Revenue        
Total revenue, net $ 656 $ 596 $ 1,944 $ 2,098